Posted in | News | Nanobusiness

Mazda to Showcase 2010 MAZDA3 Featuring World's First Vehicle Catalyst Constructed with Single Nanotechnology

Mazda Motor Corporation will showcase the world premiere of the all-new 2010 MAZDA3 5-Door at the Bologna Motor Show on December 3, 2008. The launch of the MAZDA3 5-Door follows on the heels of the debut of the 4-Door sedan, which made its world premiere at the current Los Angeles Auto Show. The all-new MAZDA3 5-Door adopts the same characteristics as its sedan counterpart, offering sporty driving and dynamic design, together with top-class environmental and safety performance.

All 2010 MAZDA3 5-Door models will be equipped with the newly developed 2.5L engine, shared with the MAZDA3s 4-Door and MAZDA6i. The 2.5L engine found in the MAZDA3 produces 167 horsepower and 168 lb.-ft. of torque.

The new 2.5L engine, as well as the 2.0L engine also available on the MAZDA3i 4-Door sedan, features the world's first vehicle catalyst to be constructed with single nanotechnology, which controls even finer material structures than nanotechnology. This new development enables Mazda to reduce its use of scarce resources such as platinum and palladium. Environmental qualities were top of mind during vehicle development, including efficient powertrains and aerodynamics that place the MAZDA3 amongst the best in class.

The all-new MAZDA3 5-Door will be revealed during Mazda's press conference at 9:00 a.m. on December 3, 2008 (local time).

Headquartered in Irvine, Calif., Mazda North American Operations oversees the sales, marketing, parts and customer service support of Mazda vehicles in the United States, Canada and Mexico through nearly 900 dealers. Operations in Canada are managed by Mazda Canada, Inc., located in Ontario, Canada, and in Mexico by Mazda Motor de Mexico in Mexico City.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.